OK Biotech Co., Ltd. (TPE:4155)

Market Cap	2.07B
Revenue (ttm)	1.64B
Net Income (ttm)	68.75M
Shares Out	141.38M
EPS (ttm)	0.47
PE Ratio	31.02
Forward PE	n/a
Dividend	0.30 (2.05%)
Ex-Dividend Date	Jul 4, 2025

Volume	185,158
Average Volume	162,585
Open	14.70
Previous Close	14.65
Day's Range	14.55 - 14.70
52-Week Range	13.80 - 22.30
Beta	0.13
RSI	47.61
Earnings Date	Mar 26, 2026

About OK Biotech

OK Biotech Co., Ltd. develops, manufactures, markets, and sells blood glucose monitoring devices and related homecare medical products in Taiwan and internationally. It also provides glucometers and blood glucose test strips; nebulizer, portable nebulizer, mesh nebulizer, and test strips; and personal sound amplifiers. OK Biotech Co., Ltd. was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4155

Financial Performance

In 2024, OK Biotech's revenue was 1.67 billion, an increase of 40.11% compared to the previous year's 1.19 billion. Earnings were 93.98 million, an increase of 3087.75%.